BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33311468)

  • 1. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis.
    Jutzi D; Campagne S; Schmidt R; Reber S; Mechtersheimer J; Gypas F; Schweingruber C; Colombo M; von Schroetter C; Loughlin FE; Devoy A; Hedlund E; Zavolan M; Allain FH; Ruepp MD
    Nat Commun; 2020 Dec; 11(1):6341. PubMed ID: 33311468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
    Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
    Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.
    Sun S; Ling SC; Qiu J; Albuquerque CP; Zhou Y; Tokunaga S; Li H; Qiu H; Bui A; Yeo GW; Huang EJ; Eggan K; Zhou H; Fu XD; Lagier-Tourenne C; Cleveland DW
    Nat Commun; 2015 Jan; 6():6171. PubMed ID: 25625564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP.
    Yu Y; Reed R
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8608-13. PubMed ID: 26124092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.
    Chi B; O'Connell JD; Iocolano AD; Coady JA; Yu Y; Gangopadhyay J; Gygi SP; Reed R
    Nucleic Acids Res; 2018 Dec; 46(22):11939-11951. PubMed ID: 30398641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
    Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.
    Tsuiji H; Iguchi Y; Furuya A; Kataoka A; Hatsuta H; Atsuta N; Tanaka F; Hashizume Y; Akatsu H; Murayama S; Sobue G; Yamanaka K
    EMBO Mol Med; 2013 Feb; 5(2):221-34. PubMed ID: 23255347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.
    Yamazaki T; Chen S; Yu Y; Yan B; Haertlein TC; Carrasco MA; Tapia JC; Zhai B; Das R; Lalancette-Hebert M; Sharma A; Chandran S; Sullivan G; Nishimura AL; Shaw CE; Gygi SP; Shneider NA; Maniatis T; Reed R
    Cell Rep; 2012 Oct; 2(4):799-806. PubMed ID: 23022481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. tRIP-seq reveals repression of premature polyadenylation by co-transcriptional FUS-U1 snRNP assembly.
    Masuda A; Kawachi T; Takeda JI; Ohkawara B; Ito M; Ohno K
    EMBO Rep; 2020 May; 21(5):e49890. PubMed ID: 32189459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
    Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
    Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.
    Chi B; O'Connell JD; Yamazaki T; Gangopadhyay J; Gygi SP; Reed R
    Sci Rep; 2018 Jun; 8(1):8755. PubMed ID: 29884807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
    Vance C; Rogelj B; Hortobágyi T; De Vos KJ; Nishimura AL; Sreedharan J; Hu X; Smith B; Ruddy D; Wright P; Ganesalingam J; Williams KL; Tripathi V; Al-Saraj S; Al-Chalabi A; Leigh PN; Blair IP; Nicholson G; de Belleroche J; Gallo JM; Miller CC; Shaw CE
    Science; 2009 Feb; 323(5918):1208-1211. PubMed ID: 19251628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Yokoi S; Ito T; Sahashi K; Nakatochi M; Nakamura R; Tohnai G; Fujioka Y; Ishigaki S; Udagawa T; Izumi Y; Morita M; Kano O; Oda M; Sone T; Okano H; Atsuta N; Katsuno M; Okada Y; Sobue G
    J Neurosci; 2022 Nov; 42(47):8881-8896. PubMed ID: 36261283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.